Baclofen extended release - Sun Pharma Advanced Research Company

Drug Profile

Baclofen extended release - Sun Pharma Advanced Research Company

Alternative Names: Baclofen ER capsules - Sun Pharma Advanced Research Company; Baclofen GRS

Latest Information Update: 05 Feb 2016

Price : $50

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Muscle spasticity
  • Suspended Alcoholism

Most Recent Events

  • 05 Feb 2016 Baclofen extended release is still in phase III trials for Spasticity in USA
  • 10 Jun 2015 Suspended - Phase-II for Alcoholism in India (PO)
  • 10 Jun 2015 Suspended - Preclinical for Alcoholism in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top